In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus
about
Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrenceDominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression.Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator.Experimental preemptive immunotherapy of murine cytomegalovirus disease with CD8 T-cell lines specific for ppM83 and pM84, the two homologs of human cytomegalovirus tegument protein ppUL83 (pp65).Rat cytomegalovirus major immediate-early enhancer switching results in altered growth characteristics.Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth.Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected hostRequirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication.Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis.Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissuesIn vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro.A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation.Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivationRole of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionBile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription.Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.
P2860
Q33800239-49A6FC21-A882-4ADA-AB06-505560517BFBQ33820723-D9B3340B-DA09-4A96-BC61-38C7C288B94AQ33834411-6A73EC21-D74A-44C0-9516-534417EAB86EQ33837150-C4D859CE-57A1-4F98-858F-944C10121D70Q33843590-1E8F28A8-ED29-4292-82BB-F1F439756692Q33851712-16E813AE-233D-4440-B142-444BA7371EE3Q33865510-22BDC705-BF23-4BE2-8E53-D954CE8228ABQ33877530-2CA2CF4A-8B4B-487F-984A-DA06811C6899Q33908684-819A9BAD-C296-4501-B96C-85FC4D45901CQ34326898-4262C575-8A60-4843-B5E5-34EBD864BB83Q34327234-E53A1619-7885-4D3E-948F-CAA321E1ED2CQ34647659-CAAEB5A2-6274-420A-A451-105026B4BE1EQ34743775-761C32F7-6362-4819-BEEE-037DF45A519CQ34755471-A7373B43-50BE-4926-9F7E-63BD51048C3CQ36371228-09DABEFD-E03F-4722-91E1-583C6434CF80Q36934001-BFD06E3C-D93C-4F95-88A2-640244CF7B07Q36934017-B63DBDB6-F480-4C35-AE56-056BD0C04569Q36944091-94FBCDDD-F653-47CD-B92C-DD5FD34A169AQ36960167-DECBB99B-71CC-40D1-ADAA-19B5C1054CD0Q36974716-25A7CDE7-0348-4B60-B18E-F64183A8C54EQ37333761-873DED91-4D7E-4A7B-933F-8E9DE296DCA3Q37596556-8E25D254-54CA-48E3-BEBF-DC5517D641A0Q39441251-DCDCA142-507C-4CC0-80A1-7C5CC5EC33D5Q39627859-4A47DEF8-808B-49AF-80E2-BD38943A8547Q39773021-C2125935-3A79-49E1-AECA-983754CC57B2Q41987319-9913FE2B-10FB-41E6-84A7-5EB1FC8EC6EBQ55514469-5151565A-A665-443D-8465-D6E22AD5E332
P2860
In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
In vivo replication of recombi ...... ancer of human cytomegalovirus
@ast
In vivo replication of recombi ...... ancer of human cytomegalovirus
@en
type
label
In vivo replication of recombi ...... ancer of human cytomegalovirus
@ast
In vivo replication of recombi ...... ancer of human cytomegalovirus
@en
prefLabel
In vivo replication of recombi ...... ancer of human cytomegalovirus
@ast
In vivo replication of recombi ...... ancer of human cytomegalovirus
@en
P2093
P2860
P1433
P1476
In vivo replication of recombi ...... ancer of human cytomegalovirus
@en
P2093
Grzimek NK
Holtappels R
Reddehase MJ
Steffens HP
P2860
P304
P577
1999-06-01T00:00:00Z